Established T cell-inflamed tumors rejected after adaptive resistance was reversed by combination STING activation and PD-1 pathway blockade

Ellen Moore, Paul E. Clavijo, Ruth Davis, Harrison Cash, Carter Van Waes, Young Kim, Clint Allen

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Established T cell-inflamed tumors rejected after adaptive resistance was reversed by combination STING activation and PD-1 pathway blockade'. Together they form a unique fingerprint.

Medicine & Life Sciences